{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2020-Q-1295\" and posted_year = 2020 sorted by posted_date descending", "rows": [["FDA-2020-Q-1295-0021", "FDA", "FDA-2020-Q-1295", "Reference 16 - Insulin and Ketone Responses to Ingestion of Medium and Long-chain Triglyercides in Man", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:58:09Z", null, 0, 0, "09000064844f9fd1"], ["FDA-2020-Q-1295-0003", "FDA", "FDA-2020-Q-1295", "Filing Letter signed", "Other", "Letter(s)", "2020-04-30T04:00:00Z", 2020, 4, "2020-04-30T04:00:00Z", null, "2020-04-30T12:56:00Z", null, 0, 0, "09000064844fb10e"], ["FDA-2020-Q-1295-0025", "FDA", "FDA-2020-Q-1295", "Reference 20 - A new way to produce hyperketonemia - Use of ketone ester in a case of Alzheimer's Disease", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:58:35Z", null, 0, 0, "09000064844f9fd5"], ["FDA-2020-Q-1295-0015", "FDA", "FDA-2020-Q-1295", "Reference 10 - Treatment of Parkinson Disease with Diet Induced Hyperketonemia - A Feasibillity Study", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:57:23Z", null, 0, 0, "09000064844fb167"], ["FDA-2020-Q-1295-0022", "FDA", "FDA-2020-Q-1295", "Reference 17 - Hyperketonemia Induced in Man by Medium-Chain  Triglyceride", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:58:16Z", null, 0, 0, "09000064844f9fd2"], ["FDA-2020-Q-1295-0014", "FDA", "FDA-2020-Q-1295", "Reference 9 - Migraine improvement during short lasting ketogenesis - a proof-of-concept study", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:57:17Z", null, 0, 0, "09000064844fb166"], ["FDA-2020-Q-1295-0018", "FDA", "FDA-2020-Q-1295", "Reference 13 - Can Ketosis Help Migraine Sufferers A Case Study", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:57:47Z", null, 0, 0, "09000064844f9fce"], ["FDA-2020-Q-1295-0024", "FDA", "FDA-2020-Q-1295", "Reference 19 - Composition of Weight Lost during Short-Term  Weight Reduction", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:58:28Z", null, 0, 0, "09000064844f9fd4"], ["FDA-2020-Q-1295-0007", "FDA", "FDA-2020-Q-1295", "Reference 2  - Ketones - Metabolism's Ugly Duckling", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:56:30Z", null, 0, 0, "09000064844fb115"], ["FDA-2020-Q-1295-0013", "FDA", "FDA-2020-Q-1295", "Reference 8 - Ketone body therapy - from the ketogenic diet to the oral administration of ketone ester", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:57:10Z", null, 0, 0, "09000064844fb165"], ["FDA-2020-Q-1295-0019", "FDA", "FDA-2020-Q-1295", "Reference 14 - Diet transiently improves migraine in two twin sisters- possible role of Ketogenesis", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:57:54Z", null, 0, 0, "09000064844f9fcf"], ["FDA-2020-Q-1295-0004", "FDA", "FDA-2020-Q-1295", "Appendix B", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:56:10Z", null, 0, 0, "09000064844fb112"], ["FDA-2020-Q-1295-0001", "FDA", "FDA-2020-Q-1295", "QHC Petition for Caprylic and Capric Acid and Migraine", "Other", "Qualified Health Claims", "2020-04-30T04:00:00Z", 2020, 4, "2020-04-30T04:00:00Z", "2020-06-30T03:59:59Z", "2020-04-30T12:55:43Z", null, 0, 0, "09000064844fb10c"], ["FDA-2020-Q-1295-0011", "FDA", "FDA-2020-Q-1295", "Reference 6 - Potential Protective Mechanisms of Ketone Bodies in Migraine Prevention", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:56:58Z", null, 0, 0, "09000064844fb163"], ["FDA-2020-Q-1295-0006", "FDA", "FDA-2020-Q-1295", "Reference 1 - Studies Compare the Burdens of Chronic and Episodic Migraine", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:56:22Z", null, 0, 0, "09000064844fb114"], ["FDA-2020-Q-1295-0023", "FDA", "FDA-2020-Q-1295", "Reference 18 - Starvation-Induced Ketosis - Reduction in Dogs Enriched with Odd-Carbon Fatty Acids", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:58:22Z", null, 0, 0, "09000064844f9fd3"], ["FDA-2020-Q-1295-0008", "FDA", "FDA-2020-Q-1295", "Reference 3 - A study of oxidative stress in migraine with special reference to prophylactic therapy", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:56:36Z", null, 0, 0, "09000064844fb160"], ["FDA-2020-Q-1295-0020", "FDA", "FDA-2020-Q-1295", "Reference 15 Cortical functional correlates of responsiveness to short lasting preventive intrvention with", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:58:03Z", null, 0, 0, "09000064844f9fd0"], ["FDA-2020-Q-1295-0010", "FDA", "FDA-2020-Q-1295", "Reference 5 - The ketone metabolite hydroxybutyrate blocks NLRP3 Inflamatory Mediated Inflamatory Disease", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:56:49Z", null, 0, 0, "09000064844fb162"], ["FDA-2020-Q-1295-0002", "FDA", "FDA-2020-Q-1295", "Acknowledgment Letter", "Other", "Acknowledgement Letter/Receipt", "2020-04-30T04:00:00Z", 2020, 4, "2020-04-30T04:00:00Z", null, "2020-04-30T12:55:53Z", null, 0, 0, "09000064844fb10d"], ["FDA-2020-Q-1295-0016", "FDA", "FDA-2020-Q-1295", "Reference 11 - Biomarkers, ketone bodies, and the prevention of Alzheimer's Disease", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:57:30Z", null, 0, 0, "09000064844fb169"], ["FDA-2020-Q-1295-0005", "FDA", "FDA-2020-Q-1295", "Appendix C", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:56:16Z", null, 0, 0, "09000064844fb113"], ["FDA-2020-Q-1295-0009", "FDA", "FDA-2020-Q-1295", "Reference 4 - Modulation of oxidative stress and mitochondrial function by the ketogenic diet", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:56:43Z", null, 0, 0, "09000064844fb161"], ["FDA-2020-Q-1295-0012", "FDA", "FDA-2020-Q-1295", "Reference 7 - Ketogenic diet in migraine treatment-A Brief but Ancient History", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:57:03Z", null, 0, 0, "09000064844fb164"], ["FDA-2020-Q-1295-0017", "FDA", "FDA-2020-Q-1295", "Reference 12 - An Experience with a Ketogenic Dietary in Migraine", "Supporting & Related Material", "Background Material", "2020-04-30T04:00:00Z", 2020, 4, null, null, "2020-04-30T12:57:40Z", null, 0, 0, "09000064844f9fcd"]], "truncated": false, "filtered_table_rows_count": 25, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2020-Q-1295", "p1": "2020"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2020-Q-1295&posted_year=2020", "results": [{"value": "FDA", "label": "FDA", "count": 25, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-Q-1295&posted_year=2020&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2020-Q-1295&posted_year=2020", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 22, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-Q-1295&posted_year=2020&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-Q-1295&posted_year=2020&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2020-Q-1295&posted_year=2020", "results": [{"value": 2020, "label": 2020, "count": 25, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-Q-1295", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-Q-1295&posted_year=2020&_facet=subtype"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-Q-1295&posted_year=2020&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-Q-1295&posted_year=2020&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-Q-1295&posted_year=2020&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-Q-1295&posted_year=2020&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 2667.3640890512615, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}